Richard J. Buka

673 total citations
19 papers, 379 citations indexed

About

Richard J. Buka is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Richard J. Buka has authored 19 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Immunology and 4 papers in Genetics. Recurrent topics in Richard J. Buka's work include Platelet Disorders and Treatments (4 papers), Food Allergy and Anaphylaxis Research (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Richard J. Buka is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Food Allergy and Anaphylaxis Research (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Richard J. Buka collaborates with scholars based in United Kingdom, Canada and Australia. Richard J. Buka's co-authors include Mamidipudi Thirumala Krishna, Aarnoud Huissoon, Charles Craddock, Richard Baretto, S. C. Beck, Justin Loke, Scott Hackett, Matthew W Cooke, Shamyla Siddique and Jenny Byrne and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Richard J. Buka

13 papers receiving 371 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Richard J. Buka 178 138 67 66 51 19 379
Malini Bhole 79 0.4× 27 0.2× 125 1.9× 59 0.9× 9 0.2× 11 294
Soo Keol Lee 152 0.9× 16 0.1× 120 1.8× 130 2.0× 21 0.4× 11 299
Lesley Woods 13 0.1× 55 0.4× 106 1.6× 41 0.6× 20 0.4× 9 285
Véronique Lamarque 23 0.1× 16 0.1× 190 2.8× 27 0.4× 23 0.5× 7 288
José Miguel Couselo 118 0.7× 5 0.0× 76 1.1× 47 0.7× 83 1.6× 13 332
G Barbano 83 0.5× 38 0.3× 76 1.1× 43 0.7× 12 0.2× 17 284
Dirk Tomsitz 9 0.1× 44 0.3× 44 0.7× 19 0.3× 6 0.1× 23 207
Daniel Tesfa 48 0.3× 9 0.1× 140 2.1× 16 0.2× 10 0.2× 7 350
Helga Haugom Olsen 35 0.2× 15 0.1× 58 0.9× 38 0.6× 10 0.2× 7 345
Evan S. Vista 18 0.1× 12 0.1× 136 2.0× 24 0.4× 7 0.1× 13 311

Countries citing papers authored by Richard J. Buka

Since Specialization
Citations

This map shows the geographic impact of Richard J. Buka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Buka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Buka more than expected).

Fields of papers citing papers by Richard J. Buka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Buka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Buka. The network helps show where Richard J. Buka may publish in the future.

Co-authorship network of co-authors of Richard J. Buka

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Buka. A scholar is included among the top collaborators of Richard J. Buka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Buka. Richard J. Buka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Hibbs, Stephen P., et al.. (2025). Can health inequalities in sickle cell disease be addressed through novel therapies?. HemaSphere. 9(7). e70175–e70175.
4.
Nicolson, Phillip L.R., Samantha J. Montague, Richard J. Buka, et al.. (2025). Anti‐PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT‐like and VITT‐like characteristics. British Journal of Haematology. 206(6). 1737–1742. 3 indexed citations
5.
6.
Buka, Richard J., Bryar Kadir, Andrew J. Doyle, et al.. (2024). Rapido: Results from a UK-Wide Audit of 2477 Patients Who Received a Reversal Agent for a Direct Oral Anticoagulant. Blood. 144(Supplement 1). 2637–2637.
7.
Buka, Richard J., et al.. (2024). Fatal drug reaction to andexanet alfa: a case report. SHILAP Revista de lepidopterología. 5(4). 829–832.
8.
Buka, Richard J. & Sue Pavord. (2024). Anti‐platelet factor 4 immunothrombotic syndromes. British Journal of Haematology. 205(4). 1291–1295.
9.
Buka, Richard J., et al.. (2023). PF4 activates the c-Mpl–Jak2 pathway in platelets. Blood. 143(1). 64–69. 20 indexed citations
10.
Gomez, Keith, et al.. (2023). How will UK hospitals use andexanet alfa? A review of local protocols. SHILAP Revista de lepidopterología. 4(1). 298–300. 3 indexed citations
11.
Montague, Samantha J., et al.. (2023). Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand. Journal of Thrombosis and Haemostasis. 22(1). 271–285. 4 indexed citations
12.
Buka, Richard J., et al.. (2022). UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease. SHILAP Revista de lepidopterología. 4(1). 13–17. 1 indexed citations
13.
Loke, Justin, Richard J. Buka, & Charles Craddock. (2021). Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?. Frontiers in Immunology. 12. 659595–659595. 49 indexed citations
14.
Buka, Richard J., et al.. (2020). Treatment of paediatric eczema with narrowband ultraviolet light B therapy. Photodermatology Photoimmunology & Photomedicine. 37(2). 105–110. 2 indexed citations
15.
Beck, S. C., et al.. (2019). Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives. Frontiers in Immunology. 10. 494–494. 94 indexed citations
16.
Gilchrist, Francis, et al.. (2018). Clinical indications and scanning protocols for chest CT in children with cystic fibrosis: a survey of UK tertiary centres. BMJ Paediatrics Open. 2(1). e000367–e000367. 6 indexed citations
17.
Buka, Richard J., Rebecca Knibb, Aarnoud Huissoon, et al.. (2017). Anaphylaxis and Clinical Utility of Real-World Measurement of Acute Serum Tryptase in UK Emergency Departments. The Journal of Allergy and Clinical Immunology In Practice. 5(5). 1280–1287.e2. 35 indexed citations
18.
Craddock, Charles, Shamyla Siddique, Christina Yap, et al.. (2015). Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial. Biology of Blood and Marrow Transplantation. 22(2). 385–390. 128 indexed citations
19.
Buka, Richard J., et al.. (2015). Anaphylaxis and ethnicity: higher incidence in British South Asians. Allergy. 70(12). 1580–1587. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malini Bhole Breakdown of academic impact, for papers by Soo Keol Lee Breakdown of academic impact, for papers by Lesley Woods Breakdown of academic impact, for papers by Véronique Lamarque Breakdown of academic impact, for papers by José Miguel Couselo Breakdown of academic impact, for papers by G Barbano Breakdown of academic impact, for papers by Dirk Tomsitz Breakdown of academic impact, for papers by Daniel Tesfa Breakdown of academic impact, for papers by Helga Haugom Olsen Breakdown of academic impact, for papers by Evan S. Vista
Rankless by CCL
2026